BNP Paribas Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

BNP Paribas Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-116,440	Closed	-$1.53M	–	2090
2025 Q1	$1.53M	Hold	116,440	–	–	﹤0.01%	711
2024 Q4	$1.84M	Hold	116,440	–	–	﹤0.01%	710
2024 Q3	$1.85M	Hold	116,440	–	–	﹤0.01%	690
2024 Q2	$1.77M	Hold	116,440	–	–	﹤0.01%	700
2024 Q1	$1.71M	Buy	116,440 +1,460	+1%	+$21.3K	﹤0.01%	690
2023 Q4	$1.6M	Hold	114,980	–	–	﹤0.01%	696
2023 Q3	$1.54M	Hold	114,980	–	–	﹤0.01%	687
2023 Q2	$1.45M	Buy	114,980 +44,670	+64%	+$521K	﹤0.01%	698
2023 Q1	$801K	Hold	70,310	–	–	﹤0.01%	770
2022 Q4	$728K	Hold	70,310	–	–	﹤0.01%	805
2022 Q3	$736K	Hold	70,310	–	–	﹤0.01%	776
2022 Q2	$779K	Hold	70,310	–	–	﹤0.01%	810
2022 Q1	$784K	Hold	70,310	–	–	﹤0.01%	759
2021 Q4	$920K	Buy	70,310 +9,825	+16%	+$124K	﹤0.01%	783
2021 Q3	$788K	Buy	60,485 +18,165	+43%	+$242K	﹤0.01%	771
2021 Q2	$622K	Hold	42,320	–	–	﹤0.01%	799
2021 Q1	$520K	Hold	42,320	–	–	﹤0.01%	775
2020 Q4	$603K	Hold	42,320	–	–	﹤0.01%	748
2020 Q3	$589K	Hold	42,320	–	–	﹤0.01%	728
2020 Q2	$449K	Hold	42,320	–	–	﹤0.01%	702
2020 Q1	$341K	Hold	42,320	–	–	﹤0.01%	717
2019 Q4	$343K	Sell	42,320 -2,270	-5%	-$17.9K	﹤0.01%	756
2019 Q3	$338K	Sell	44,590 -2,385	-5%	-$17.7K	﹤0.01%	779
2019 Q2	$352K	Sell	46,975 -45,265	-49%	-$356K	﹤0.01%	819
2019 Q1	$747K	Sell	92,240 -87,115	-49%	-$662K	0.01%	744
2018 Q4	$1.35M	Buy	179,355 +54,975	+44%	+$387K	0.01%	658
2018 Q3	$861K	Hold	124,380	–	–	0.01%	727
2018 Q2	$801K	Sell	124,380 -192,680	-61%	-$1.22M	0.01%	774
2018 Q1	$2.07M	Buy	317,060 +173,040	+120%	+$1.21M	0.02%	630
2017 Q4	$1.08M	Hold	144,020	–	–	0.01%	721
2017 Q3	$1.03M	Sell	144,020 -32,660	-18%	-$235K	0.01%	738
2017 Q2	$1.49M	Hold	176,680	–	–	0.01%	697
2017 Q1	$1.42M	Sell	176,680 -21,625	-11%	-$187K	0.01%	709
2016 Q4	$1.8M	Hold	198,305	–	–	0.02%	669
2016 Q3	$1.84M	Sell	198,305 -2,100	-1%	-$20K	0.02%	736
2016 Q2	$2.05M	Sell	200,405 -21,810	-10%	-$200K	0.02%	691
2016 Q1	$2.01M	Buy	222,215 +3,415	+2%	+$30.5K	0.02%	685
2015 Q4	$2.03M	Hold	218,800	–	–	0.02%	665
2015 Q3	$2.8M	Hold	218,800	–	–	0.02%	597
2015 Q2	$2.42M	Sell	218,800 -46,850	-18%	-$517K	0.02%	668
2015 Q1	$3.03M	Hold	265,650	–	–	0.02%	619
2014 Q4	$2.68M	Sell	265,650 -2,280	-0.9%	-$24K	0.02%	558
2014 Q3	$2.82M	Hold	267,930	–	–	0.02%	553
2014 Q2	$2.31M	Buy	267,930 +47,585	+22%	+$400K	0.02%	617
2014 Q1	$1.94M	Hold	220,345	–	–	0.01%	652
2013 Q4	$1.81M	Hold	220,345	–	–	0.01%	652
2013 Q3	$1.67M	Buy	220,345 +66,195	+43%	+$481K	0.01%	628
2013 Q2	$1.17M	Buy	+154,150	New	+$1.13M	0.01%	640

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BNP Paribas Asset Management's RDY Position: Q2 2025 in Review

BNP Paribas Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 116,440 shares — an estimated $1.53M sold.

BNP Paribas Asset Management first reported a position in RDY in Q2 2013 and held it in 48 quarters. The position peaked at $3.03M in Q1 2015. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

BNP Paribas Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
BNP Paribas Asset Management sold 116,440 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $1.53M.
BNP Paribas Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 48 quarters.
BNP Paribas Asset Management's Dr. Reddy's Laboratories position peaked at $3.03M in Q1 2015.
243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on BNP Paribas Asset Management's 13F filing for Q2 2025, filed 6 Aug 2025.